Mendelian randomization analysis provides insights into the relationship between inflammatory bowel disease and skin cancer.
Systemic Therapies for Metastatic Melanoma.
Dermatol Clin. 2025;43(3):483-494 - PMID: 40581428 - DOI: 10.1016/j.det.2025.03.004
Acral Melanoma: A Review of Its Pathogenesis, Progression, and Management.
Recent progress in cancer vaccines and nanovaccines.
Biomaterials. 2024;314:122856 - PMID: 39366184 - DOI: 10.1016/j.biomaterials.2024.122856
Update on the Pathogenesis of Keloid Formation.
JID Innov. 2024;4(6):100299 - PMID: 39247523 - PMCID: PMC11378114 - DOI: 10.1016/j.xjidi.2024.100299
ATLAS: A positive, high-yield review of patient symptoms most significantly associated with melanoma recurrence.
J Am Acad Dermatol. 2024;91(6):1118-1124 - PMID: 39197498 - DOI: 10.1016/j.jaad.2024.07.1516
Differential time series analysis shows deceleration in melanoma mortality prior to the widespread use of highly effective therapies.
J Am Acad Dermatol. 2024;91(5):872-879 - PMID: 39038555 - PMCID: PMC11653201 - DOI: 10.1016/j.jaad.2024.07.1457
Fabrication and functional validation of a hybrid biomimetic nanovaccine (HBNV) against Kit K641E -mutant melanoma.
Bioact Mater. 2024;46:347-364 - PMID: 39834347 - PMCID: PMC11742834 - DOI: 10.1016/j.bioactmat.2024.12.023
Analysis of Variants Induced by Combined Ex Vivo Irradiation and In Vivo Tumorigenesis Suggests a Role for the ZNF831 p.R1393Q Variant in Cutaneous Melanoma Development.
J Invest Dermatol. 2024;145(7):1728-1739.e7 - PMID: 39675662 - DOI: 10.1016/j.jid.2024.08.042
Lentigo Maligna Part II: Management.
J Am Acad Dermatol. 2024;:ePub - PMID: 39447752 - DOI: 10.1016/j.jaad.2024.07.1534
Lentigo Maligna Part I: Epidemiology, Risk Factors, and Diagnosis.
J Am Acad Dermatol. 2024;:ePub - PMID: 39442885 - DOI: 10.1016/j.jaad.2024.09.065
Molecular Analysis of Murine KitK641E Melanoma Progression.
JID Innov. 2024;4(3):100266 - PMID: 38585193 - PMCID: PMC10995915 - DOI: 10.1016/j.xjidi.2024.100266
Multiple de novo spitzoid nevi arising within a specific red tattoo ink.
JAAD Case Rep. 2024;46:78-80 - PMID: 38577501 - PMCID: PMC10992272 - DOI: 10.1016/j.jdcr.2024.02.012
Germline cancer susceptibility in individuals with melanoma.
J Am Acad Dermatol. 2024;91(2):265-272 - PMID: 38513832 - DOI: 10.1016/j.jaad.2023.11.070
Geotemporal Analysis of Melanoma Incidence and Mortality Identifies Distinct Clusters of Trends within the United States Between 2001 and 2019.
J Invest Dermatol. 2024;145(2):393-399.e1 - PMID: 38981567 - PMCID: PMC11704087 - DOI: 10.1016/j.jid.2024.05.032
Keratinocytic skin cancers-Update on the molecular biology.
Cancer. 2023;129(6):836-844 - PMID: 36645692 - DOI: 10.1002/cncr.34635
Ultrasound-guided supraclavicular block versus Bier block for emergency reduction of upper limb injuries: a protocol for an open-label, non-inferiority, randomised controlled trial.
Acquired brachial cutaneous dyschromatosis.
JAAD Case Rep. 2023;37:110-113 - PMID: 37396486 - PMCID: PMC10314224 - DOI: 10.1016/j.jdcr.2023.05.007
Development and validation of time-to-event models to predict metastatic recurrence of localized cutaneous melanoma.
J Am Acad Dermatol. 2023;90(2):288-298 - PMID: 37797836 - PMCID: PMC10843255 - DOI: 10.1016/j.jaad.2023.08.105
Mendelian Randomization Analysis reveals Inverse Genetic Risks between Skin Cancers and Vitiligo.
JID Innov. 2023;3(6):100217 - PMID: 38034848 - PMCID: PMC10685305 - DOI: 10.1016/j.xjidi.2023.100217
Resilience of melanoma diagnostics at a tertiary-care hospital during the SARS-CoV-2 pandemic.
Melanoma classification and management in the era of molecular medicine.
Dermatol Clin. 2022;41(1):49-63 - PMID: 36410983 - DOI: 10.1016/j.det.2022.07.017
Divergent BRAF Inhibitor Resistance Mechanisms Revealed through Epigenetic Mapping.
J Invest Dermatol. 2022;143(5):842-853.e6 - PMID: 36529262 - DOI: 10.1016/j.jid.2022.03.039
Oncogenic KIT Induces Replication Stress and Confers Cell Cycle Checkpoint Vulnerability in Melanoma.
J Invest Dermatol. 2021;142(5):1413-1424.e6 - PMID: 34687746 - DOI: 10.1016/j.jid.2021.07.188
In vivo coherent Raman imaging of the melanomagenesis-associated pigment pheomelanin.
25